華潤醫藥(03320.HK)：博雅生物上半年淨利增16.88%至3.26億元

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

華潤醫藥(03320.HK)：博雅生物上半年淨利增16.88%至3.26億元

格隆匯 08-22 06:22

格隆匯8月22日丨華潤醫藥(03320.HK)發佈公吿，博雅生物(300294.SZ)2023年半年度實現營業收入人民幣15.41億元，同比增長10.16%；歸屬於博雅生物股東的淨利3.26億元，同比增長16.88%；歸屬於博雅生物股東的扣除非經常性損益的淨利潤2.57億元，同比增長3.97%；基本每股收益0.65元。

華潤醫藥(03320.HK)

Relevant Stocks

華潤醫藥(03320.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

華潤醫藥(03320.HK)：博雅生物上半年淨利增16.88%至3.26億元

Services

About Us

Agreement Statement